Ketter TA - Search Results

1

Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.

Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA. Reilly-Harrington NA, et al. Among authors: ketter ta. J Affect Disord. 2016 Nov 15;205:159-164. doi: 10.1016/j.jad.2016.07.007. Epub 2016 Jul 5. J Affect Disord. 2016. PMID: 27449548 Clinical Trial.

2

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics.

Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Corá-Locatelli G, Post RM. Frye MA, et al. Among authors: ketter ta. J Affect Disord. 1998 Mar;48(2-3):91-104. doi: 10.1016/s0165-0327(97)00160-2. J Affect Disord. 1998. PMID: 9543198 Review.

3

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression.

Winsberg ME, DeGolia SG, Strong CM, Ketter TA. Winsberg ME, et al. Among authors: ketter ta. J Affect Disord. 2001 Dec;67(1-3):207-12. doi: 10.1016/s0165-0327(01)00434-7. J Affect Disord. 2001. PMID: 11869770 Clinical Trial.

4

Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.

Ketter TA, Calabrese JR. Ketter TA, et al. J Clin Psychiatry. 2002 Feb;63(2):146-51. doi: 10.4088/jcp.v63n0210. J Clin Psychiatry. 2002. PMID: 11874216 Review.

5

Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?

Li X, Ketter TA, Frye MA. Li X, et al. Among authors: ketter ta. J Affect Disord. 2002 May;69(1-3):1-14. doi: 10.1016/s0165-0327(00)00361-x. J Affect Disord. 2002. PMID: 12103447 Review.

6

Gabapentin augmentation therapy in bipolar depression.

Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA. Wang PW, et al. Among authors: ketter ta. Bipolar Disord. 2002 Oct;4(5):296-301. doi: 10.1034/j.1399-5618.2002.01211.x. Bipolar Disord. 2002. PMID: 12479661 Clinical Trial.

7

Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.

Janenawasin S, Wang PW, Lembke A, Schumacher M, Das B, Santosa CM, Mongkolcheep J, Ketter TA. Janenawasin S, et al. Among authors: ketter ta. Bipolar Disord. 2002 Oct;4(5):328-34. doi: 10.1034/j.1399-5618.2002.01210.x. Bipolar Disord. 2002. PMID: 12479666 Clinical Trial.

8

Temperament characteristics of child and adolescent bipolar offspring.

Chang KD, Blasey CM, Ketter TA, Steiner H. Chang KD, et al. Among authors: ketter ta. J Affect Disord. 2003 Oct;77(1):11-9. doi: 10.1016/s0165-0327(02)00105-2. J Affect Disord. 2003. PMID: 14550931

9

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A. Tohen M, et al. Among authors: ketter ta. Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. doi: 10.1001/archpsyc.60.11.1079. Arch Gen Psychiatry. 2003. PMID: 14609883 Clinical Trial.

10

Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.

Marangell LB, Martinez JM, Ketter TA, Bowden CL, Goldberg JF, Calabrese JR, Miyahara S, Miklowitz DJ, Sachs GS, Thase ME; STEP-BD Investigators. Marangell LB, et al. Among authors: ketter ta. Bipolar Disord. 2004 Apr;6(2):139-43. doi: 10.1111/j.1399-5618.2004.00098.x. Bipolar Disord. 2004. PMID: 15005752 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page